Effect of S-1 on pharmacokinetics of irinotecan in a patient with colorectal cancer

Clin Pharmacol Ther. 2006 Oct;80(4):422-4. doi: 10.1016/j.clpt.2006.06.012.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Antineoplastic Agents, Phytogenic / pharmacokinetics*
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacokinetics
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / metabolism*
  • Drug Combinations
  • Humans
  • Irinotecan
  • Middle Aged
  • Oxonic Acid / pharmacology*
  • Tegafur / pharmacology*
  • Time Factors

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Irinotecan
  • Camptothecin